| For: | Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, Ray P, Dhiman RK, Chawla Y. Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(42): 9346-9355 [PMID: 27895422 DOI: 10.3748/wjg.v22.i42.9346] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i42/9346.htm |
| Number | Citing Articles |
| 1 |
Surya Prakash Bhatt, Anoop Misra, Ravindra Mohan Pandey. rs7903146 (C/T) polymorphism of Transcription factor 7 like 2 (TCF7L-2) gene is independently associated with non-alcoholic fatty liver disease in Asian Indians. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(3) doi: 10.1016/j.dsx.2020.02.011
|
| 2 |
Naoko Ohtani, Eiji Hara. Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota. Cancer Science 2021; 112(11) doi: 10.1111/cas.15142
|
| 3 |
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen. Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review. Nutrients 2022; 14(21) doi: 10.3390/nu14214556
|
| 4 |
Angelica Carreira dos Santos, Daniel Araki Ribeiro, Jessica Almeida da Cruz Ferreira, Odair Aguiar, Dan Linetzky Waitzberg, Claudia Cristina Alves. Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental nonalcoholic fatty liver disease. Nutrition & Food Science 2019; 49(1) doi: 10.1108/NFS-04-2018-0119
|
| 5 |
Ramasamy Selvarani, HoangVan Michelle Nguyen, Natesan Pazhanivel, Muthusamy Raman, Sunho Lee, Roman F. Wolf, Sathyaseelan S. Deepa, Arlan Richardson. The role of inflammation induced by necroptosis in the development of fibrosis and liver cancer in novel knockin mouse models fed a western diet. GeroScience 2024; 47(3) doi: 10.1007/s11357-024-01418-3
|
| 6 |
Ya Guo, Yedan Liu, Jie Song, Peipei Liu, Sifei Wu, Yuxia Tan, Fan Fan, Zongbo Chen. Association of CD14 rs2569190 G/A genetic polymorphism with the severity of enterovirus 71 infection in Chinese children. Virology 2020; 548 doi: 10.1016/j.virol.2020.06.001
|
| 7 |
Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.975027
|
| 8 |
Ana Cláudia M.B. Gomes Torres, Neiva Leite, Luciane Viater Tureck, Ricardo Lehtonen Rodrigues de Souza, Ana Cláudia Kapp Titski, Gerusa Eisfeld Milano-Gai, Leilane Lazarotto, Larissa Rosa da Silva, Lupe Furtado-Alle. Association between Toll-like receptors (TLR) and NOD-like receptor (NLR) polymorphisms and lipid and glucose metabolism. Gene 2019; 685 doi: 10.1016/j.gene.2018.11.065
|
| 9 |
Alexander J. Kovalic, Pratik Banerjee, Quynh T. Tran, Ashwani K. Singal, Sanjaya K. Satapathy. Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2018; 8(4) doi: 10.1016/j.jceh.2018.04.001
|
| 10 |
Jinchunzi Yang, Marta Fernández-Galilea, Leyre Martínez-Fernández, Pedro González-Muniesa, Adriana Pérez-Chávez, J. Alfredo Martínez, Maria J. Moreno-Aliaga. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation. Nutrients 2019; 11(4) doi: 10.3390/nu11040872
|
| 11 |
Iulia Cristina Marginean, Sergiu Marian Cazacu, Cristina Maria Marginean, Mihaela Popescu, George Alexandru Iacob, Marian Sorin Popescu, Cristin Constantin Vere. Is MASLD Not Just a Liver Disease? Bidirectional Gut–Liver Crosstalk as a Driver of Chronic Liver Disease. Life 2026; 16(7) doi: 10.3390/life16071076
|
| 12 |
Jennifer Nguyen, Jingjing Jiao, Kristin Smoot, Gordon P. Watt, Chen Zhao, Xingzhi Song, Heather L. Stevenson, Joseph B. McCormick, Susan P. Fisher-Hoch, Jianhua Zhang, P. Andrew Futreal, Laura Beretta. Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. Oncotarget 2018; 9(50) doi: 10.18632/oncotarget.25685
|
| 13 |
Eglė Žilienė, Arturas Inčiūra, Rasa Ugenskienė, Elona Juozaitytė. Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene. Diagnostics 2023; 13(12) doi: 10.3390/diagnostics13121999
|
| 14 |
YI WEI. CANDIDATE GENES AND PATHWAYS LINKING SLEEP DEPRIVATION TO OBESITY. Journal of Mechanics in Medicine and Biology 2019; 19(03) doi: 10.1142/S0219519419500106
|
| 15 |
Mingjiong Tong, Fengyong Wang. APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta‐analysis. IUBMB Life 2020; 72(8) doi: 10.1002/iub.2302
|
| 16 |
Haobing Li, Wenzhang Jin, Qi Tang, Hongkai Xu, Shunfu Wang, Xiaoying Niu, Meilin Yi, Wa Zhang, Lifei Wei, Kaixin Zhu, Ziyin Xie, Jiaqi Tian, Tingfeng Xiao, Jingang Han, Haizhen Ni. “Imposters” lurking in the extracellular matrix-mimicking hydrogel trap inflammatory mediators for the treatment of inflammatory wounds. Materials & Design 2026; 264 doi: 10.1016/j.matdes.2026.115822
|
| 17 |
Xinpei Chen, Pengcheng Zhou, Luo De, Bo Li, Song Su. The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta‐analysis of 24,147 subjects. Molecular Genetics & Genomic Medicine 2019; 7(8) doi: 10.1002/mgg3.824
|
| 18 |
Mohammad Sarhadi, Elham Pahlavani, Niloufar Hosseini Razavi, Fatemeh Ghadyani, Zahra Abdollahi, Somayeh Sarhadi, Mahboobeh Sabeti Akbar Abad, Hossein Shahriari, Mahdi Majidpour.
IL-18
and
CD14
variants in chronic HBV predisposition: a case-control study with
in silico
analyses focused on transcription and splicing
. Nucleosides, Nucleotides & Nucleic Acids 2024; 43(9) doi: 10.1080/15257770.2024.2326132
|
| 19 |
Reina Yamamoto, Yumie Takeshita, Hiromasa Tsujiguchi, Takayuki Kannon, Takehiro Sato, Kazuyoshi Hosomichi, Keita Suzuki, Yuki Kita, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Tatsuya Yamashita, Shuichi Kaneko, Atsushi Tajima, Hiroyuki Nakamura, Toshinari Takamura. Nutrigenetic Interaction Between Apolipoprotein C3 Polymorphism and Fat Intake in People with Nonalcoholic Fatty Liver Disease. Current Developments in Nutrition 2023; 7(4) doi: 10.1016/j.cdnut.2023.100051
|
| 20 |
Joeri Lambrecht, Frank Tacke. Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.634409
|
| 21 |
Sayma Yaqub, Patricia Ananias, Arpita Shah, Kanita Luenam, Arunima Mariya Jose, Joao Pedro Melo, Arifa Turkistani, Lubna Mohammed. Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review. Cureus 2021; doi: 10.7759/cureus.18201
|